Gossamer Bio, Inc. — Earnings Quality Grade C
GOSS · Healthcare
Some red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
Insufficient data
Insufficient data
Revenue -57.7%, CFFO -4838.5%. Cash follows revenue
Expense Quality
No material inventory
Insufficient data
Insufficient data
Insufficient data
Cash Flow Quality
CFFO/NI = 1.01. Profits backed by cash
FCF is negative ($-0.2B)
Accruals ratio = 0.5%. Low accruals
Cash $0.1B covers 67% of debt $0.2B
Balance Sheet Health
No goodwill. Clean balance sheet
Interest coverage = -14.9x (<2x). Financial stress
Other assets grew 44.2% vs revenue -57.7%
No write-off data
Acquisition Risk
FCF after acquisitions positive
No goodwill
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor GOSS continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25